Clinical Trials Sponsored by Avedro, Inc

Total 35557 results

Aveera Medical, Inc.

Not yet recruiting

Pivotal Trial of the Boomerang Catheter for pDVA

Chronic Limb-Threatening Ischemia
Avenzo Therapeutics, Inc.

Recruiting

Study of ARTS-021 in Patients With Advanced Solid Tumors

Solid Tumors

United States
Aveiro University

Active, not recruiting

A Pilot Study of a Neural Mobilization Intervention Applied to Older Adults With Chronic Musculoskeletal Pain

Chronic Pain | Older Adults | Chronic Musculoskeletal Pain | Chronic Musculoskeletal Disease

Portugal
Aveiro University

Completed

Effect of a Respiratory Training Program on Woodwind and Brass Players

Respiratory Function

Portugal
Aveiro University

Completed

Pain Neuroscience Education for Older Adults

Chronic Pain

Portugal
Aveiro University

Completed

Effect of Nervous System Mobilization on Older Adults' Postural Control

Older Adults

Portugal
Aveiro University

Completed

Pain Neuroscience Education and Exercise in Institutionalized Older Adults With Pain

Chronic Pain

Portugal
Aveiro University

Unknown

Neuropsychological Profile of a Patient's Group With Multiple Sclerosis and Effect of a Cognitive Rehabilitation Program (MS_Rehab)

Cognitive Dysfunction
Akero Therapeutics, Inc

Recruiting

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NASH/MASH | NAFLD/MASLD

United States, Canada, Puerto Rico, Australia, India
Akero Therapeutics, Inc

Active, not recruiting

A Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) (Harmony)

NASH - Nonalcoholic Steatohepatitis

United States, Puerto Rico
Aveiro University

Completed

Acute Effects of Action Observation on Neck Pain

Neck Pain

Portugal
Aveiro University

Completed

Immediate Exercise-Induced Hypoalgesia in Patients With Chronic Low Back Pain

Low Back Pain

Portugal
Aveiro University

Completed

Pain Neuroscience Education and Gradual Exposure to Exercise in Factory Workers With Chronic Low Back Pain

Low Back Pain

Portugal
Aveiro University

Completed

Effect of Nervous System Mobilization on Athletes' Performance

Healthy

Portugal
Aveiro University

Completed

Table to Tablet (T2T): A Novel Intervention Framework for Children With Speech Sound Disorders

Speech Disorders

Portugal
Aveiro University

Unknown

Exercise and Pain Neuroscience Education for Patients With Neck Pain: Impact on Pain and Disability

Neck Pain

Portugal
Aveiro University

Completed

Visual Feedback in Chronic Low Back Pain of Pregnant and Nonpregnant Women

Low Back Pain

Portugal
Aveiro University

Completed

Pain Neuroscience Education and Exercise

Neck Pain
Aveiro University

Completed

Impact of Feedback on Physical Activity and Health-related Outcomes During Pulmonary Rehabilitation in COPD

Pulmonary Disease, Chronic Obstructive
Akero Therapeutics, Inc

Recruiting

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis | MASH With Fibrosis

United States, Canada, Puerto Rico, Australia, India, France, Italy, Poland, Spain
Akero Therapeutics, Inc

Active, not recruiting

A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)

NASH - Nonalcoholic Steatohepatitis

United States, Mexico, Puerto Rico
Akero Therapeutics, Inc

Completed

A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)

NASH - Nonalcoholic Steatohepatitis

United States, Puerto Rico
Aveiro University

Recruiting

Impact of Respiratory Physiotherapy in Children With Bronchiolitis in the First Two Years of Life

Bronchiolitis

Portugal
Aveiro University

Completed

Impact of a Technology Mediated Dance Intervention

Older Adults Without Any Specific Clinical Condition

Portugal
Aveiro University

Completed

Effects of the FIFA 11+ on Physical Performance and Injury Prevention in Female Futsal Players

Injuries | Balance | Flexibility

Portugal
Aveiro University

Unknown

Pulmonary Rehabilitation Innovation and Microbiota in Exacerbations of COPD (PRIME)

COPD | COPD Exacerbation

Portugal
Aveiro University

Completed

Visual Feedback in Chronic Neck Pain

Neck Pain

Portugal
Aveiro University

Completed

Effects of Nervous System Mobilization

Healthy Individuals

Portugal
Aveiro University

Completed

Pain Neurophysiology Education and Exercise for Adolescents With Chronic Idiopathic Neck Pain

Neck Pain
AVEO Pharmaceuticals, Inc.

Completed

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma

United States, Canada
AVEO Pharmaceuticals, Inc.

Completed

An Extension Treatment Protocol for Subjects Who Have Participated in a Study of Tivozanib Versus Sorafenib in Kidney Carcinoma (Protocol AV-951-09-301).

Advanced Renal Cell Carcinoma

United States, Bulgaria, Canada, Chile, Czechia, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom
AVEO Pharmaceuticals, Inc.

Completed

A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer

Lung Neoplasms | Respiratory Tract Neoplasms | Lung Cancer | Carcinoma, Non-Small Cell-Lung

Hong Kong, Korea, Republic of, Malaysia, Philippines, Singapore, Taiwan, Thailand
AVEO Pharmaceuticals, Inc.

Completed

A Phase 1 Dose Escalation Study of AV-203, an ERBB3 Inhibitory Antibody, in Subjects With Advanced Solid Tumors

Solid Tumors

United States
AVEO Pharmaceuticals, Inc.

Completed

A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function

Hepatic Impairment

United States
AVEO Pharmaceuticals, Inc.

Completed

A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors

Advanced Solid Tumors | Locally Advanced or Metastatic Breast or Colorectal Cancer

United States
AVEO Pharmaceuticals, Inc.

Completed

Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers

Colorectal Cancer | Gastrointestinal Cancer

Netherlands
AVEO Pharmaceuticals, Inc.

Completed

An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

United States
AVEO Pharmaceuticals, Inc.

Completed

A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients

Advanced Cancer | Refractory Cancer

United States
AVEO Pharmaceuticals, Inc.

Terminated

Safety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor Malignancies

Tumor

United States, Argentina
AVEO Pharmaceuticals, Inc.

Completed

A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC)

Carcinoma, Renal Cell

United States, Hungary, Spain, United Kingdom, Italy, Germany, France, Belgium, Czechia, Canada, Denmark, Poland
AVEO Pharmaceuticals, Inc.

Completed

A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma (TIVO-1)

Advanced Renal Cell Carcinoma

United States, Argentina, Bulgaria, Canada, Chile, Czechia, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom
AVEO Pharmaceuticals, Inc.

No longer available

Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient

Mullerian Mixed Tumor of Ovary

United States
AVEO Pharmaceuticals, Inc.

Completed

A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy

Colorectal Cancer

United States, Hungary, United Kingdom, Australia, Spain, Netherlands, Italy, Czech Republic, Canada, Austria, Belgium, Finland
AVEO Pharmaceuticals, Inc.

Completed

A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer

United States, Germany
AVEO Pharmaceuticals, Inc.

Completed

A Single Center, Open-label, Randomized, Two-period Crossover Food Effect Study of Single Doses of Tivozanib (AV-951) in Healthy Subjects

Food Effect of Tivozanib in Health Subjects

United States
AVEO Pharmaceuticals, Inc.

Completed

A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases

Liver Metastases | Malignant Solid Tumour

Spain
AVEO Pharmaceuticals, Inc.

Completed

A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma

United States
AVEO Pharmaceuticals, Inc.
Biodesix, Inc.

Terminated

A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label (FOCAL)

Non-small Cell Lung Cancer

Korea, Republic of, United States, Australia, Taiwan, Singapore, Hong Kong, Italy
AVEO Pharmaceuticals, Inc.

Recruiting

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma (FIERCE-HN)

Recurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head-and-neck Squamous-cell Carcinoma

United States, Australia
AVEO Pharmaceuticals, Inc.

Recruiting

A Dose Escalation Study of AV-380 in Metastatic Cancer Patients With Cachexia

Cachexia

United States

3

Subscribe